Atlas Trials

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients

Clinical trial NCT05688046 · COMPLETED

Trial details

NCT number
NCT05688046
Sponsor
Suzhou Municipal Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
NSCLC
Start date
2019-01-01
Primary completion
2022-08-01
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.